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Attachment of positively charged, amine-containing
residues such as 4-amino-4-deoxy-L-arabinose (L-Ara4N)
and phosphoethanolamine (pEtN) to Escherichia coli
and Salmonella typhimurium lipid A is required for resistance to the cationic antimicrobial peptide, polymyxin. In an attempt to discover additional lipid A modifications important for polymyxin resistance, we
generated polymyxin-sensitive mutants of an E. coli pmrAC strain, WD101. A subset of polymyxin-sensitive mutants produced a lipid A that lacked both the 3ⴕ-acyloxyacyl-linked myristate (C14) and L-Ara4N, even
though the necessary enzymatic machinery required to
synthesize L-Ara4N-modified lipid A was present. Inactivation of lpxM in both E. coli and S. typhimurium resulted in the loss of L-Ara4N addition, as well as, increased sensitivity to polymyxin. However, decoration
of the lipid A phosphate groups with pEtN residues was
not effected in lpxM mutants. In summary, we demonstrate that attachment of L-Ara4N to the phosphate
groups of lipid A and the subsequent resistance to polymyxin is dependent upon the presence of the secondary
linked myristoyl group.

Lipopolysaccharide (LPS)1 is the major surface molecule of
Gram-negative bacteria and is held in the outer membrane by
a unique phospholipid domain known as lipid A. The typical
lipid A backbone consists of a ␤-1⬘,6-linked disaccharide of
glucosamine that is phosphorylated and multiply acylated. In
Escherichia coli and Salmonella enterica serovar Typhimurium
(Salmonella typhimurium), the disaccharide backbone is acylated at the 2-, 3-, 2⬘-, and 3⬘-positions with (R)-3-hydroxymyristate and phosphorylated at the 1- and 4⬘-positions (1). A
secondary lauroyl (C12) and myristoyl (C14) group is attached at
the 2⬘- and 3⬘-positions, respectively, of the distal glucosamine
in an acyloxyacyl linkage resulting in the hexa-acylated struc-
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ture shown in Fig. 1A (1). The lipid A domain is attached to the
polysaccharide portion of LPS via the Kdo (3-deoxy-D-mannooctulosonic acid) sugars (Fig. 1) (1).
Modification of the lipid A domain of E. coli and S. typhimurium with the cationic sugar 4-amino-4-dexoy-L-arabinose
(L-Ara4N) and phosphoethanolamine (pEtN) promotes resistance to the cyclic antimicrobial lipopeptide, polymyxin (2–5).
Although the mechanism of polymyxin killing is not completely
understood, the peptide is thought to access the outer surface of
the bacterium by interacting with the negatively charged phosphate groups of lipid A. A similar mechanism is employed by
cationic antimicrobial peptides of the innate immune system
(6). Masking of lipid A phosphate groups with positively
charged amine-containing residues is predicted to decrease
binding of polymyxin to the bacterial surface promoting survival. In E. coli and S. typhimurium, the polymyxin-resistant
phenotype is primarily under the control of the PmrA/PmrB
two-component regulatory system that is activated during
growth under conditions of low pH, high Fe3⫹, and in a
PhoP/PhoQ-dependent manner during Mg 2⫹ starvation
(7–9).
Previously, Trent and co-workers (10) demonstrated that
periplasmic addition of L-Ara4N to lipid A is catalyzed by
L-4-aminoarabinose transferase (ArnT), a PmrA-regulated glycosyltransferase (10). Because the transferase utilizes an undecaprenyl-linked donor substrate, undecaprenyl-phosphate-␣L-Ara4N, its active site is predicted to lie in the periplasmic
region of the cell (11). Furthermore, Doerrler et al. (12) have
demonstrated that modification of lipid A with L-Ara4N and
pEtN is dependent upon its transport across the inner membrane by MsbA. We now report that, in E. coli K12 and
S. typhimurium, addition of L-Ara4N to the lipid A domain of
LPS in living cells is dependent upon the presence of the
acyloxyacyl-linked myristoyl group at the 3⬘-position. Loss of
myristoylation of lipid A in both E. coli and S. typhimurium by
inactivation of lpxM resulted in loss of L-Ara4N modification
and in a significant decrease in polymyxin resistance. However,
the pEtN modification of the lipid A phosphate groups was not
effected by loss of myristoylation.
EXPERIMENTAL PROCEDURES

Chemicals and Other Materials—[␥-32P]ATP and 32Pi were obtained
from Amersham International. Silica Gel 60 (0.25-mm) thin layer plates
were purchased from EM Separation Technology (Merck). Yeast extract
and Tryptone were from Difco. Triton X-100 and bicinchoninic acid were
from Pierce. Polymyxin B sulfate was purchased from Sigma. All other
chemicals were reagent grade and were purchased from either Sigma
or Mallinckrodt.
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TABLE I
Strains and plasmids
Strain or plasmid

Description

Source or Ref.

E. coli
W3110
WD101
MLK1067
WD103
F2–1
C1–1
A3–1

Wild type, F⫺, ⫺
W3110, pmrAc, polymyxinr
W3110, lpxM::⍀cam
WD101, lpxM::⍀cam
WD101 polymyxins mutant
WD101 polymyxins mutant
WD101 polymyxins mutant

S. typhimurium
C5
C5 lpxM::kan
C5 lpxM::kan/pR1A
C5 lpxM::kan/pRM17A

Wild type mouse virulent strain
Kanr
Kanr,Ampr
Kanr,Ampr

28
28
This work
This work

Plasmids
pR1A
pRM17A
pWSK29
pWSLpxM

Derivative of pACYC177, Ampr
pR1A containing S. typhimurium lpxM
Low-copy expression vector, Ampr
pWSK29 containing E. coli lpxM

This work
This work
15
This work

E. coli Genetic Stock Center, Yale University
11
13, 14
This work
This work
This work
This work

FIG. 1. Structure of the modified Kdo2-lipid A of E. coli and S. typhimurium. The covalent modifications of lipid A are indicated with
dashed bonds, and lengths of the acyl chains are designated with enclosed circles. Panel A, the lipid A backbone of E. coli and S. typhimurium is
a hexa-acylated disaccharide of glucosamine that is substituted at the 1- and 4⬘-positions with phosphate and glycosylated at the 6⬘-position with
two Kdo (3-deoxy-D-manno-octulosonic acid) moieties (1, 43). In wild type E. coli K12 strains, a portion of the lipid A contains a pyrophosphate
group at the 1-position (36). Acyl chains catalyzed by the so-called late acyltransferases, LpxL and LpxM, are indicated. Panel B, the modification
of phosphate moieties of lipid A is regulated by PmrA (5) and may be substituted with L-Ara4N or pEtN groups. In addition, the protein product
of the PhoP-activated gene, pagP, further modifies lipid A by the addition of a palmitoyl chain to the hydroxyl group of the N-linked-R-3hydroxymyristate chain on the proximal glucosamine unit of lipid A. In Salmonella, 2-hydroxymyristate can be found in place of myristate. The
reported enzymes required for their respective modifications are indicated in the figure.
Bacterial Strains and Growth Conditions—Bacterial strains are described in Table I. Typically bacteria were grown at 37 °C in LB broth
containing 10 g of NaCl, 10 g of Tryptone, and 5 g of yeast extract per
liter. When required for plasmid selection, cells were grown in the
presence of 100 g/ml ampicillin, 12 g/ml tetracycline, 30 g/ml chloramphenicol, or 30 g/ml kanamycin.
Recombinant DNA Techniques—Plasmids were isolated using the Qiagen Spin Prep Kit. Custom primers were obtained from Integrated DNA
Technologies. PCR reagents were purchased from Stratagene. PCR clean
up was performed using the Qiaquick PCR Purification Kit (Qiagen).
DNA fragments were isolated from gels using the Qiaquick Gel Extraction
Kit (Qiagen). Restriction endonucleases, T4 DNA ligase, and shrimp alkaline phosphatase were purchased from New England Biolabs. All modifying enzymes were used according to the manufacturer’s instructions.
Isolation of Polymyxin-sensitive Mutants—Polymyxin-sensitive
mutants were generated by random mutagenesis of the E. coli strain,
WD101. WD101, a polymyxin-resistant E. coli K12 strain, contains a
mutation in the pmrA (basR) gene resulting in a pmrAC phenotype
promoting polymyxin resistance (11). E. coli WD101 was treated with
40 g/ml of the mutagen N-methyl-N⬘-nitro-N-nitrosoguanidine for

10 min at 37 °C. To obtain clones that were sensitive to polymyxin,
mutagenized cells were first grown on LB agar plates (⬃100/plate).
Sensitive mutants were identified by replica plating onto LB agar
plates containing 2 g/ml polymyxin B sulfate at 37 °C. Sensitive
clones were re-purified and their sensitivity to polymyxin verified.
Approximately 10,000 colonies were screened by the above method,
and ⬃100 polymyxin-sensitive mutants were identified including
strains F2-1 and C1-1.
Generation of E. coli Strain WD103—WD103 was generated by P1vir
transduction of the polymyxin-resistant genotype (pmrAC) of strain
WD101 into the E. coli lpxM mutant MLK1067 (W3110 lpxM::⍀cam)
(13, 14).
Construction of LpxM Covering Plasmids, pWSLpxM and pRM17A—
E. coli lpxM was cloned into the multiple cloning site of the low-copy
expression vector pWSK29 (15) resulting in plasmid pWSLpxM. The
latter was used to complement the pmrAC E. coli lpxM mutant, WD103.
The S. typhimurium lpxM covering plasmid was constructed by subcloning the Salmonella lpxM gene into a pACYC derivative, pR1A. The
resulting plasmid was named pRM17A and was used to complement the
S. typhimurium lpxM mutant.
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FIG. 2. Comparison of 32P-labeled
lipid A of polymyxin-sensitive derivatives of E. coli WD101. 32P-Labeled
lipid A species from polymyxin-sensitive
mutants generated by random chemical
mutagenesis of E. coli strain WD101 were
isolated as described under “Experimental Procedures.” The labeled lipid A species were separated by TLC using the solvent chloroform, pyridine, 88% formic
acid, water (50:50:16:5, v/v), and visualized by phosphorimaging. The proposed
lipid A species are indicated based upon
previous work by Zhou et al. (16, 36).
Lipid A from the polymyxin-sensitive
strain W3110 and the polymyxin-resistant strain WD101 were analyzed as
controls.

Isolation and Analysis of 32P-Labeled Lipid A Species— 32P iLabeled lipid A was isolated from cells uniformly labeled with 2.5
Ci/ml of 32Pi in 5 ml of LB broth as previously described (16). The
32
P-labeled lipid A domain was released from LPS by hydrolysis of the
Kdo dissacharide and processed by the method of Zhou and coworkers (16). Lipids were spotted onto a Silica Gel 60 TLC plate
(10,000 cpm/lane) and developed in the solvent chloroform, pyridine,
88% formic acid, water (50:50:16:5, v/v). Labeled lipids were visualized by phosphorimaging.
Isolation and Analysis of 32P-Labeled Undecaprenyl-Phosphate-␣-LAra4N—Cells were uniformly labeled with 32Pi as described above. The
glycerolphospholipid fraction containing the undecaprenyl-phosphate␣-L-Ara4N was isolated and analyzed by TLC as described by Trent and
co-workers (11).
Preparation of Cell-free Extracts, Double-Spun Cytosol, and Washed
Membranes—Typically, 200-ml cultures of E. coli or S. typhimurium
were grown at 37 °C to an A600 of 1.0 and harvested by centrifugation at
6,000 ⫻ g for 30 min. All samples were prepared at 4 °C. Cell-free
extract, double-spun cytosol, and washed membranes were prepared as
previously described (17) and were stored in aliquots at ⫺20 °C. Protein
concentration was determined by the bicinchoninic acid method (18),
using bovine serum albumin as the standard.
Preparation of [4⬘-32P]Lipid IVA—The substrate [4⬘-32P]lipid IVA was
generated from 100 Ci of [␥-32P]ATP and the tetraacyldisaccharide
1-phosphate lipid acceptor, using the overexpressed 4⬘-kinase present
in membranes of E. coli BLR(DE3)/pLysS/pJK2 (17, 19, 20), as previously described (17, 20).
Assay of E. coli ArnT—The ArnT was assayed as previously described
by Trent and co-workers using [4⬘-32P]lipid IVA as the substrate (10).
Addition of the L-Ara4N was visualized as a shift to a slower migrating
lipid species previously termed Lipid IIA (21).
Polymyxin Sensitivity Assays—E. coli and S. typhimurium strains
were assayed for polymyxin resistance as described by Gunn and Miller
(8). After growth to an A600 nm of ⬃0.5, bacteria were diluted to ⬃2,500
colony forming units/ml in LB broth. Cells (200 l) were treated for 1 h
at 37 °C with increasing concentrations of polymyxin in a microtiter
plate. Following exposure to polymyxin, 100 l of treated bacteria were
plated on LB agar plates and incubated overnight at 37 °C. Colony
counts were determined for each concentration of polymyxin tested, and

the results were expressed as the percentage of colonies resulting from
untreated cells.
Large Scale Isolation of Lipid A—E. coli or S. typhimurium were
cultured in 200 ml of LB medium at 37 °C or N-minimal media containing 10 M Mg2⫹, respectively. The cultures were allowed to reach an
A600 nm ⬃ 0.8, harvested by centrifugation at 6000 ⫻ g for 15 min, and
washed once with phosphate-buffered saline. The final cell pellets were
resuspended in 20 ml of phosphate-buffered saline. Lipid A was released from cells and purified as previously described (16, 22), and
stored frozen at ⫺20 °C. Prior to mass spectrometry various lipid A
species were separated by anion-exchange chromatography as previously described (22, 37).
Mass Spectrometry of Lipid A Species—Mass spectra of the purified
lipids were acquired in the negative ion mode using a matrix-assisted
laser desorption-ionization-time of flight (MALDI-TOF) mass spectrometer (AXIMA-CFR, Kratos Analytical, Manchester, UK),
equipped with a nitrogen laser (337 nm). The instrument was operated using 20-kV extraction voltage and time-delayed extraction,
providing a mass resolution of about ⫾1 atomic mass units for compounds with Mr ⬃ 2000. Each spectrum represented the average of
100 laser shots. Saturated 6-aza-2-thiothymine in 50% acetonitrile
and 10% tribasic ammonium citrate (9:1, v/v) served as the matrix.
The samples were dissolved in chloroform/methanol (4:1, v/v), and
deposited on the sample plate followed by an equal portion of matrix
solution (0.3 l). The sample was dried at 25 °C prior to mass
analysis.
RESULTS

Isolation and Characterization of Polymyxin-sensitive Mutants of E. coli WD101—Addition of the amine-containing residues, L-Ara4N and pEtN, to the phosphate groups of lipid A
(Fig. 1) is associated with increased resistance to cationic antimicrobial peptides, including the peptide polymyxin (2–5).
E. coli strain WD101 contains a mutation in the pmrA gene
resulting in a pmrAC phenotype and modification of the lipid A
structure with L-Ara4N and pEtN, helping to provide resistance to polymyxin at concentrations of up to 20 g/ml on solid
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FIG. 3. Detection of the L-Ara4N donor lipid and L-Ara4N transferase activity in polymyxin-sensitive mutants C1-1 and F2-1. Panel
A, 32P-labeled phospholipids were isolated from the indicated strains as described under “Experimental Procedures” and separated by TLC. The
migration of undecaprenyl-phosphate-␣-L-Ara4N is indicated, and based on work by Trent and co-workers (11). Panel B, membranes from the
indicated strains were assayed for the presence of the L-Ara4N-lipid A transferase (ArnT) activity as previously described (10). Formation of the
slower migrating species, lipid IIA, was indicative of ArnT activity.

media (10). Originally, we sought to determine additional modifications to the lipid A structure that were important for polymyxin resistance. Using WD101 as the parent strain, a library
of mutants displaying sensitivity to polymyxin at 2 g/ml was
generated via random chemical mutagenesis. Approximately
10,000 colonies were replica plated on LB agar containing 2
g/ml of polymyxin, and ⬃100 colonies showing sensitivity to
the peptide were purified for further analysis. Each mutant
was uniformly labeled in the presence of 32Pi, and the lipid A
fraction analyzed by TLC. Fig. 2 shows the modification patterns found in the lipid A fractions isolated from selected polymyxin-sensitive mutants.
Overall, four different lipid A phenotypes were found among
the polymyxin-sensitive mutants. For example, some mutants
produced lipid A identical to that of wild type E. coli strain
W3110. W3110 synthesizes a bis-phosphorylated hexa-acylated
lipid A species lacking modified phosphate groups (Fig. 2, lane
1) and shows sensitivity to polymyxin at concentrations ⬍0.1
g/ml on solid media (data not shown). Mutant B1-1 produced
lipid A species (Fig. 2, lane 4) identical to those of the WD101
parent strain (Fig. 2, lane 2) modified with L-Ara4N, and pEtN
yet showed sensitivity to the peptide at 2 g/ml. These results
suggest that other mechanisms involved in conferring polymyxin resistance to E. coli may remain as yet unidentified. As
expected, in some cases sensitivity arose from the inability to
synthesize L-Ara4N- or pEtN-modified species. For example,
strain A1-1 (Fig. 2, lane 3) produced lipid A modified with one
or two pEtN residues, whereas mutant D1-1 produced species
modified with only L-Ara4N (lane 6). The changes in the lipid A
domain of A1-1 and D1-1 most likely arose from lack of L-Ara4N
or pEtN transferase activities, respectively (data not shown).
Finally, strains C1-1 and F2-1 produced very hydrophilic lipid
A species that had not been previously identified, and for this
reason these strains were chosen for further analysis.

Strains C1-1 and F2-1 Have the Enzymatic Machinery to
Synthesize and Transfer L-Ara4N to Lipid A—Transfer of
L-Ara4N to lipid A occurs in the periplasmic region of the cell
catalyzed by the inner membrane glycosyltransferase, ArnT.
The enzyme utilizes an undecaprenyl carrier lipid, undecaprenyl-phosphate-␣-L-Ara4N, as the donor substrate (10, 11). Loss
of ArnT function or the inability to synthesize the undecaprenyl-linked substrate results in loss of polymyxin resistance (5,
23). Because mutants C1-1 and F2-1 showed sensitivity to
polymyxin, we determined if these mutants contained the necessary enzymatic machinery to synthesize and transfer
L-Ara4N to the lipid A domain of their LPS. The phospholipid
fraction from 32Pi-labeled cells was analyzed by TLC for the
presence of the undecaprenyl-phosphate-␣-L-Ara4N donor
lipid. As previously shown by Trent et al. (11), the L-Ara4N
donor lipid was produced by the polymyxin-resistant strain
WD101 (Fig. 3A, lane 1), but absent in the polymyxin-sensitive
wild type strain, W3110 (lane 2). However, examination of the
phospholipid fraction from mutants C1-1 and F2-1 (Fig. 3A,
lanes 3 and 4) showed the presence of the L-Ara4N donor lipid.
Furthermore, mutants C1-1 and F2-1 contained functional
ArnT. Membranes isolated from either C1-1 or F2-1 catalyzed
the transfer of L-Ara4N from the donor substrate to [4⬘32
P]lipid IVA (Fig. 3B, lanes 4 and 5), a tetra-acylated bisphosphorylated precursor of lipid A. From this data we were
able to conclude that a decrease in polymyxin resistance in
strains C1-1 and F2-1 did not arise from the inability to produce or transfer L-Ara4N to lipid A.
Analysis of Lipid A Produced by Polymyxin-sensitive Mutants C1-1 and F2-1 by MALDI-TOF Mass Spectrometry—The
lipid A species of mutants C1-1 or F2-1 were isolated as previously described and separated based upon charge using anionexchange chromatography (16, 22). Mass spectrometry of the
lipid A species containing unmodified phosphate groups re-
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FIG. 4. Negative ion MALDI-TOF mass spectrometry of lipid A
from E. coli polmyxin-sensitive derivative C1-1. Lipid A of E. coli
strain C1-1 was isolated and fractionated by DEAE-cellulose chromatography using published protocols (16). Mass spectrometry data were
acquired in the negative ion mode for all lipids eluting from the DEAE
column. However, only the most representative data are shown. Data
shown in panels A and B are from lipids eluting in the 120 and 60 mM
salt fractions, respectively. Identical data were seen for the mutant
F2-1.

vealed the presence of a penta-acylated bis-phosphorylated
species as indicated by [M-H]⫺ at m/z 1587.6 in the negative
mode. The major ion peak at 1587.6 (Fig. 4A) corresponds to the
loss of myristate (C14) from E. coli lipid A that is found in E. coli
mutants lacking a functional myristoyltransferase, LpxM
(MsbB) (24, 25). The majority of the penta-acylated lipid was
modified with either one or two pEtN groups as indicated by
major ion peaks at m/z 1710.6 (Fig. 4A) and 1832.6 (Fig. 4B),
respectively. Interestingly, mutants C1-1 or F2-1 were unable
to produce lipid A modified with L-Ara4N even though both
mutants contain the necessary enzymatic machinery required
for transfer of L-Ara4N to lipid A (see Fig. 3). The only additional modification present was addition of palmitate (C16) to
species containing either one or two pEtN groups producing
minor ion peaks at m/z 1948.9 and 2071.4, respectively (Fig. 4).
Addition of the palmitoyl group is catalyzed by the outer membrane enzyme, PagP (26, 27). This data were suggestive that
the increased polymyxin sensitivity seen displayed by mutants
C1-1 or F2-1 resulted from a loss of L-Ara4N addition. Second,

these results suggest that myristoylation of E. coli lipid A in
vivo is a requirement for L-Ara4N addition.
Generation and Characterization of a pmrAC, lpxM::⍀cam E.
coli Mutant—To determine whether loss of L-Ara4N modification in mutants C1-1 and F2-1 arose from a loss of addition of
myristate to lipid A, we constructed the E. coli strain WD103.
A P1vir bacteriophage lysate of polymyxin-resistant WD101
was used to transduce the pmrAC mutation into an existing E.
coli lpxM (msbB) mutant, MLK1067 (13, 14). The resulting
strain was referred to as WD103. Cultures of the various mutants and their corresponding parent strains were labeled with
32
Pi, and the lipid A fraction isolated to determine possible
modifications in vivo. As expected, the polymyxin-sensitive
parent strains MLK1067 (Fig. 5, lane 3) and W3110 (Fig. 5,
lane 1) produced unmodified penta- or hexa-acylated lipid A,
respectively. The lipid A species shown in lane 5 isolated from
WD103 (pmrAC, lpxM::⍀cam) were found to migrate with identical RF values of those isolated from mutants C1-1 (Fig. 5, lane
4) or F2-1 (data not shown).
Complementation of strain WD103 with a low-copy vector
expressing E. coli lpxM, pWSLpxM, resulted in production of
lipid A identical to that found in the polymyxin-resistant
parent strain WD101 (Fig, 5, lane 7). This was not the case
when WD103 was complemented with the empty vector control, pWSK29 (lane 6). Analysis of the lipid A fraction of
E. coli WD103/pWSK29 by MALDI-TOF mass spectrometry
produced results identical to those shown in Fig. 4 for the
polymyxin-sensitive mutant C1-1 (data not shown). WD103/
pWSK29 produced pEtN-modified lipid A lacking both myristate and L-Ara4N. However, the lipid A of WD103/pWSLpxM
produced major ions at m/z 1929.7, 2052.7, and 2290.7, corresponding to hexa-acylated lipid A modified with L-Ara4N
(Fig. 5B). Table II provides a summary of the lipid A species
of strains C1-1 and WD103/pWSLpxM identified by mass
spectrometry.
Myristoylation of S. typhimurium Lipid A Enhances Addition of L-Ara4N—Because myristoylation of LPS appears to
determine the extent of L-Ara4N addition to the lipid A domain
of E. coli K-12, we investigated whether or not the same was
true for S. typhimurium LPS. Using an existing lpxM mutant
of S. typhimurium strain C5 (28), we determined the extent of
aminoarabinose addition in bacteria containing a vector control
(pR1A) or an lpxM covering plasmid (pRM17A). Salmonella
were cultured in N-minimal media under Mg2⫹-limiting conditions to activate the PhoP/PhoQ two-component regulatory system. Under these conditions, Salmonella PhoP has been shown
to induce activation of PmrA (5, 8, 29), leading to increased
substitution of lipid A phosphate groups with L-Ara4N and
pEtN (5, 23).
Previously, Khan and co-workers (28) demonstrated that
the S. typhimurium C5 lpxM mutant produced an LPS showing an approximate 10-fold decrease in the amount of myristate (C14). However, the extent to which phosphate groups
were modified with L-Ara4N was not examined. As expected,
analysis of intact lipid A from strain C5 lpxM (data not
shown), or C5 lpxM containing the empty vector pR1A by
MALDI-TOF mass spectrometry showed a major peak at m/z
1588.3 corresponding to penta-acylated lipid A (Fig. 6B). The
Salmonella lpxM mutant does produce a hexa-acylated lipid
A with a major ion peak at m/z 1826.5 (or 1826.1) atomic mass
units (Fig. 6, A and B). However, the signal at 1826.5 (or
1826.1) corresponds to a lipid A species containing palmitate
(C16) rather than myristate (C14). The lpxM mutant also
produced pEtN-modified lipid A with mass spectrometry
showing two ion peaks at m/z 1949.8 and 1977.9 (Fig. 6B)
(see Table II). Addition of L-Ara4N to the lipid A of E. coli
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FIG. 5. Analysis of lipid A species of E. coli WD103 (pmrAC, lpxM::⍀cam) and WD103/pWSLpxM. Panel A, 32P-labeled lipid A species from
the indicated strains were analyzed by TLC. The proposed modifications are indicated in parentheses for either hexa- or penta-acylated lipid A.
Strains W3110 and MLK1067 are both polymyxin-sensitive producing either the hexa- or penta-acylated lipid A species, respectively (24). Panel
B, lipid A of E. coli strain WD103 containing an lpxM covering plasmid (pWSlpxM) was processed as described in the legend of Fig. 4 and subjected
to mass spectrometry. The data shown are from lipids eluting in the 120 mM fraction. Lipid A isolated from E. coli WD103 containing the empty
vector control (pWSK29) produced mass spectrometry results identical to that of mutant C1-1 shown in Fig. 4 (data not shown).
TABLE II
Structural interpretation of lipid A species detected by MALDI/TOF mass spectrometry
Lipid A modifications

Expected [M-H]⫺

Observed [M-H]⫺

0
0
0
0
0

1588.0
1711.1
1834.1
1949.5
2072.5

1587.6
1709.7/1710.6
1832.6
1948.9
2071.4

1
1
1
1

0
0
0
0

1798.4
1929.5
2052.5
2290.9

1798.3
1929.7
2052.7
2290.7

0
0
0
0

0
0
1
1

0
0
0
0

1588.0
1719.1
1826.4
1949.5

1588.3
1718.5
1826.5
1949.8

1
1
1
1
1
1
1
1
1
1
1
1

0
0
0
0
0
0
0
1
1
1
1
1

0
1
0
1
0
1
1
0
0
1
1
1

1798.4
1814.4
1929.5
1945.5
2052.5
2068.5
2076.6
2159.8
2167.9
2175.8
2183.9
2306.9

1797.7
1813.8
1928.2
1944.5/1945.5
2052.3/2051.6
2068.2
2074.3
2159.4
2167.8
2176.2
2183.7/2182.0
2305.8/2306.3

Strain

a

L-Ara4N

pEtN

C16–0

C14–0

2-OH

E. coli C1-1a

0
0
0
0
0

0
1
2
1
2

0
0
0
1
1

0
0
0
0
0

E. coli WD103/pLpxM

0
1
1
1

0
0
1
1

0
0
0
1

S. typhimurium lpxM/pR1A

0
1
0
0

0
0
0
1

S. typhimurium lpxM/pRM17A

0
0
1
1
1
1
2
0
1
0
1
1

0
0
0
0
1
1
0
1
0
1
0
1

Similar data were obtained for E. coli strains F2-1 and WD103.

strain WD103 (pmrAC, lpxM::⍀cam) was not detectable by
mass spectrometry. However, a very minor peak at m/z
1718.5 (Fig. 6A) corresponding to the addition of a single

L-Ara4N sugar to penta-acylated lipid A of the Salmonella
mutant was present.
Complementation of the Salmonella mutant with the lpxM
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FIG. 6. Negative ion MALDI-TOF mass spectrometry of lipid A from S. typhimurium C5/pR1A (panels A and B) or C5/pRM17A
(panels C and D). Lipid A of S. typhimurium strain C5 grown under Mg2⫹-limiting (10 M) conditions was isolated and fractionated by
DEAE-cellulose chromatography as previously described (16). Panels A and B show spectra acquired for the lipid A isolated from S. typhimurium
C5 containing the low-copy vector, pR1A. Panels C and D show spectra acquired for the lipid A from S. typhimurium C5 containing the lpxM
covering plasmid, pRM17A. Peaks containing modifications to the phosphate head groups of lipid A are indicated. Mass spectrometry data were
acquired in the negative ion mode for all lipids eluting from the DEAE column, but only the most representative data are shown. Panel A, 120 mM
fraction; panel B, 240 mM fraction; panel C, 60 mM fraction; panel D, 120 mM fraction.

covering plasmid resulted in the production of lipid A species
typically seen in Salmonella grown under Mg2⫹-limiting conditions (27, 30). The amount of lipid A containing L-Ara4Nmodified species was drastically increased as compared with
the Salmonella lpxM mutant with major peaks at m/z 1945.4
(1944.5) and 2052.3 (2051.6) (Fig. 6, C and D). Additionally, a
species modified with two L-Ara4N sugars was present as indicated by the peak at 2074.3 m/z (see Table II). The mass
spectrometry data of lipid A isolated from the recovered mutant
was further complicated by the appearance of the hydroxylated
lipid A species characterized by the addition of 16 mass units.
This arises from the action of LpxO, a lipid A hydroxylase
required for the addition of 2-OH myristate to S. typhimurium
lipid A (see Table II).

Effect of Lipid Myristoylation on the Polymyxin Resistance of
E. coli and S. typhimurium Strains—E. coli WD101 harbors a
mutation in pmrA giving rise to a pmrAC phenotype resulting
in increased resistance to polymyxin. As judged by disc diffusion assays, the polymyxin-resistant phenotype is significantly
reduced upon loss of a functional copy of lpxM (see Table III). A
similar result was found when comparing the survivability of
E. coli after treatment with increasing concentrations of polymyxin in Luria broth. As shown in Fig. 7, E. coli strain WD103
showed a marked increase in polymyxin sensitivity compared
with its pmrAC parent strain, WD101. Complementation of
WD103 with the vector pWSLpxM resulted in restoration of
polymyxin resistance to the levels displayed by WD101 (Table
III and Fig. 7). Salmonella lpxM mutants grown under Mg2⫹-
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TABLE III
Increased polymyxin sensitivity of E. coli harboring an lpxM mutation
Straina

W3110
WD101
MLK1067
WD103
WD103/pWSK29
WD103/pWSlpxM
a
b

Polymyxin (zone of clearing diameter (mm)b
0.2 g

0.5 g

1.0 g

2.0 g

10.0 g

20.0 g

9
ⱕ6
8
ⱕ6
ⱕ6
ⱕ6

10
ⱕ6
9
7
ⱕ6
ⱕ6

12
ⱕ6
11
8
8
ⱕ6

13.5
ⱕ6
14
8.5
9
ⱕ6

16
9.5
16.5
12
13
10

19
12
20
15.0
15.0
12

Strains are described in Table I.
A zone of inhibition of ⱕ6 mm corresponds to complete resistance and is equal to the diameter of the disc.

FIG. 7. Effect of lpxM mutation on the polymyxin resistance of
E. coli. Strains of E. coli were treated with increasing concentrations of
polymyxin and the survival percentages determined as described under
“Experimental Procedures.” Strains WD101 and W3110 (or MLK1067)
served as polymyxin-resistant and -sensitive controls, respectively.
Plasmid pWSlpxM containing E. coli lpxM was used to complement
strain WD103. Symbols: E, WD101; 䡺, WD103 containing pWSK29
(vector control); ⌬, WD103 containing pWSlpxM; ⫻, W3110.

limiting (10 M) conditions also displayed increased sensitivity
to polymyxin that could be restored by introduction of an lpxM
covering plasmid (data not shown).
DISCUSSION

In E. coli and S. typhimurium, the synthesis of the lipid A
domain of LPS is completed by the addition of myristate catalyzed by the so-called “late” acyltransferase, LpxM (1). AcylACP serves as the acyl-donor for the acyltransferase (13),
therefore restricting the reaction to the cytoplasmic side of the
inner membrane. Lipid A attached to the core oligosaccharide
is then transported across the inner membrane by the ABC
transporter, MsbA (31, 32). Following transport to the periplasmic face, lipid A can be modified with various substituents
including the cationic sugar L-Ara4N (12). The latter is transferred from undecaprenyl-phosphate-␣-L-Ara4N (11) by the inner membrane enzyme ArnT to the phosphate groups of lipid A
(10). Addition of L-Ara4N to the lipid A domain of Gram-negative bacterial LPS helps to promote resistance to cationic antimicrobial peptides, such as polymyxin (2, 23, 33, 34).
In an attempt to identify lipid A modifications necessary for
polymyxin resistance, we isolated polymyxin-sensitive mutants
of an E. coli K12 pmrAC strain. A subset of mutants unable to
decorate their lipid A domain with L-Ara4N also failed to in-

corporate myristate at the 3⬘-position. These results were verified by constructing an E. coli strain (WD103) lacking a functional copy of lpxM, but retaining the pmrAC phenotype. This
led to the possibility that in vivo modification of LPS with
L-Ara4N requires LpxM-dependent myristoylation of the lipid
A domain. However, we felt it necessary to determine whether
the same were true for S. typhimurium.
Both E. coli and S. typhimurium synthesize a bis-phosphorylated hexa-acylated lipid A species with LpxM catalyzing the
final step before transport across the cytoplasmic membrane.
We isolated the lipid A fraction from wild type S. typhimurium,
strain C5, containing an inactivated lpxM gene grown under
conditions known to increase modification to the lipid A domain. When the Salmonella lpxM mutant was cultured under
Mg2⫹-limiting conditions, lipid A species modified with pEtN
were detected by mass spectrometry. Only a very small fraction
of the lipid A was modified with L-Ara4N when isolated from
the S. typhimurium lpxM mutant (Fig. 6, A and B). However,
upon introduction of the Salmonella lpxM gene using the covering plasmid, pRM17A, an impressive increase in L-Ara4Nmodified lipid A species were detected by mass spectrometric
analysis. Second, the bacteria produced lipid A species containing L-Ara4N attached to both phosphate groups of its lipid A
(Fig. 6, C and D).
Typically, L-Ara4N is found attached via a phosphodiester
linkage to the 4⬘-phosphate of E. coli and S. typhimurium lipid
A (16, 35, 36). However, in wild type S. typhimurium a portion
of the lipid A does contain two L-Ara4N moieties (Fig. 1) (35).
We found that inactivation of lpxM in E. coli results in a total
loss of L-Ara4N addition, whereas the Salmonella lpxM mutant
produced a very minor amount of L-Ara4N-modified lipid A.
Previously, Trent and co-workers (10) demonstrated that in
vitro the L-Ara4N transferase of Salmonella transfers L-Ara4N
to the 1-phosphate group when using the tetra-acylated lipid A
precursor, lipid IVA, as the substrate. However, if Kdo2-lipid
IVA is used as the substrate in the assay system two sugars can
be added to the molecule (10). Because Kdo-deficient S. typhimurium mutants accumulate species modified with L-Ara4N
only at the 1-position (21, 37), it was proposed that modification
of the 4⬘-phosphate group is dependent upon the presence of
the Kdo dissacharide (10). Therefore, it is likely that the small
amount of L-Ara4N present in the Salmonella lpxM mutant is
linked to the 1-phosphate group.
Based upon our present findings, perhaps efficient transfer
of L-Ara4N to the 4⬘-phosphate group of lipid A in vivo requires
both the presence of the Kdo moiety and myristate. Because
ArnT activity is partitioned in the periplasmic region of the
cell, it is reasonable that the enzyme prefers a hexa-acylated
lipid A domain for activity. A detailed study of the substrate
preference of ArnT would be required to determine the validity
of this argument. Other lipid A modifying enzymes have been
shown to require specific structural changes to their substrate
for activity. For example, Stead et al. (38) demonstrated that an
Helicobacter pylori Kdo hydrolase requires dephosphorylation
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at the 1-position by an H. pylori lipid A 1-phosphatase for
activity. Also, the outer membrane 3-O-deacylase of Salmonella, PagL, appears to be activated in the absence of L-Ara4N
modification (39). Therefore, modification of LPS within the
Gram-negative membrane can also be regulated at the enzymatic level.
On the whole, we have presented an additional phenotype of
lpxM mutants. Salmonella and E. coli lacking functional copies
of lpxM are attenuated in their ability to activate human
macrophages producing an LPS with reduced endotoxicity (28,
40). Also, lpxM mutants of either a clinical isolate of E. coli (41)
or of S. typhimurium (28, 40) show a reduction in virulence in
murine infection models. However, it should be noted that
extragenic suppressors of lpxM mutants (42) might also influence the virulence phenotype. Given our current data, it is
possible that the reduction in lethality shown by the lpxM
mutants of these organisms results, in part, from their inability
to modify their lipid A with L-Ara4N, because loss of the modification would result in increased sensitivity to cationic antimicrobial peptides.
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